| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 1.968 | 681 | 30 |
| Total Income - EUR | - | - | - | 0 | 190 | 0 | 76.696 | 672.578 | 255.666 | 991.505 |
| Total Expenses - EUR | - | - | - | 215 | 0 | 15 | 76.892 | 663.136 | 233.385 | 1.080.721 |
| Gross Profit/Loss - EUR | - | - | - | -215 | 190 | -15 | -196 | 9.442 | 22.281 | -89.216 |
| Net Profit/Loss - EUR | - | - | - | -215 | 184 | -15 | -196 | 9.136 | 19.252 | -89.216 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Evoo Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 76.696 | 662.686 | 803.593 | 1.698.688 |
| Current Assets | - | - | - | 21 | 21 | 10 | 23.907 | 104.332 | 216.387 | 187.668 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 29.001 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 15.037 | 52.781 | 41.030 |
| Cash | - | - | - | 21 | 21 | 10 | 23.907 | 89.295 | 163.606 | 117.637 |
| Shareholders Funds | - | - | - | -172 | 15 | 0 | -196 | 8.939 | 28.164 | -61.209 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 193 | 6 | 10 | 100.799 | 758.079 | 991.816 | 1.947.566 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Evoo Medical S.r.l.